Existing Innovative Trial Design, Endpoint Tools Could Be Help Ultra-Rare Sponsors Need

 
• By Derrick Gingery
  
workshop
Kerry Jo Lee said tools like model-informed drug development meeting program could be applied to ultra-rare disease drug development. • Source: Shutterstock

More from Rare Diseases

More from Conferences